Sangareddy: Two workers were injured in a fire accident that took place in Lee Pharma Ltd at Gaddapotharam Industrial Estate in Jinnaram Mandal in the district on Wednesday afternoon. As per details, a massive fire broke out at the company's production area when they were unloading solvents. The material caught fire due to spark and huge flames engulfed the place. There
Lee Pharma Ltd. announced that it has entered into a non-exclusive licensing agreement with the CSIR Indian Institute of Chemical Technology, Hyderabad (CSIR-IICT) for process know-how for the synthesis of 2-DG (2-Deoxy-D-Glucose). IICT, a constituent laboratory of the Council of Scientific and Industrial Research (CSIR) and Lee Pharma, an integrated pharmaceutical company,
Share
New Delhi: Indian Institute of Chemical Technology, (IICT), a constituent laboratory of CSIR and Lee Pharma, an integrated pharmaceutical company, based in Hyderabad have entered into a non-exclusive licensing agreement for the synthesis of 2-Deoxy-D-Glucose (2-DG). Recently, 2-DG developed by DRDO and Dr Reddy’s Laboratories has received approval for use in Covid-19 patients. It has been found to help speed up recovery and reduce oxygen dependence and Dr. Reddy’s Laboratories has launched the drug in the form of sachets.
Lee Pharma informed that they would file the application for getting the approval from DCGI, New Delhi. Lee Pharma will manufacture and commercialize the 2-DG sachets from their formulation facility located at SEZ, Duvvada, Visakhapatnam, Andhra Pradesh, which has the accreditations, by global regulatory agencies.